Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.61 +0.15 (+4.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (EOCN) Amortizatization of Intangibles (2023)

Updated

Galmed Pharmaceuticals' Amortizatization of Intangibles was -$176,000 in Q1 2023.

Analysis

Galmed Pharmaceuticals (EOCN) Amortizatization of Intangibles (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Galmed Pharmaceuticals 420,034.32 420,034.32 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -176,000.00
API Access

Galmed Pharmaceuticals Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=EOCN&period=max&api_key=YOUR_API_KEY